Neurologic complications of immune checkpoint inhibitors A Fellner, C Makranz, M Lotem, F Bokstein, A Taliansky, S Rosenberg, ... Journal of neuro-oncology 137, 601-609, 2018 | 146 | 2018 |
cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor‐3 and scavenger receptor‐AI/II in microglia … C Makranz, G Cohen, F Reichert, T Kodama, S Rotshenker Glia 53 (4), 441-448, 2006 | 79 | 2006 |
Heat tolerance in women—reconsidering the criteria A Druyan, C Makranz, D Moran, R Yanovich, Y Epstein, Y Heled Aviation, space, and environmental medicine 83 (1), 58-60, 2012 | 72 | 2012 |
Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cγ and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined … C Makranz, G Cohen, A Baron, L Levidor, T Kodama, F Reichert, ... Neurobiology of disease 15 (2), 279-286, 2004 | 52 | 2004 |
Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis F Reichert, U Slobodov, C Makranz, S Rotshenker Neurobiology of disease 8 (3), 504-512, 2001 | 52 | 2001 |
Non‐PKC DAG/Phorbol‐Ester receptor (s) inhibit complement receptor‐3 and nPKC inhibit scavenger receptor‐AI/II‐mediated myelin phagocytosis but cPKC, PI3k, and PLCγ activate … G Cohen, C Makranz, M Spira, T Kodama, F Reichert, S Rotshenker Glia 53 (5), 538-550, 2006 | 43 | 2006 |
Liquid biopsy reveals collateral tissue damage in cancer A Lubotzky, H Zemmour, D Neiman, M Gotkine, N Loyfer, S Piyanzin, ... JCI insight 7 (2), 2022 | 29 | 2022 |
Hypothermia following exertional heat stroke treatment C Makranz, Y Heled, DS Moran European journal of applied physiology 111, 2359-2362, 2011 | 15 | 2011 |
Physiological differences between heat tolerant and heat intolerant young healthy women R Yanovich, I Ketko, J Muginshtein-Simkovitch, E Yanovich, U Eliyahu, ... Research Quarterly for Exercise and Sport 90 (3), 307-317, 2019 | 12 | 2019 |
Predictors of quality of life among adults with self-reported cancer related cognitive impairment T Maeir, M Nahum, C Makranz, S Tsabari, T Peretz, Y Gilboa Disability and Rehabilitation 45 (6), 1056-1062, 2023 | 9 | 2023 |
Neurological variability in chemotherapy‑induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review C Makranz, S Khutsurauli, Y Kalish, R Eliahou, L Kadouri, JM Gomori, ... Molecular and clinical oncology 8 (1), 178-182, 2018 | 9 | 2018 |
The feasibility of a combined model of online interventions for adults with cancer-related cognitive impairment T Maeir, M Nahum, C Makranz, A Hoba, T Peretz, SN Nagary, ... British Journal of Occupational Therapy 84 (7), 430-440, 2021 | 8 | 2021 |
Early hydrocephalus in Listeria meningitis: Case report and review of the literature B Nachmias, E Orenbuch-Harroch, C Makranz, H Nechusthan, R Eliahou, ... IDCases 14, e00455, 2018 | 8 | 2018 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma E Lebel, N Goldschmidt, T Siegal, A Lossos, S Rosenberg, C Makranz, ... Leukemia & Lymphoma 63 (9), 2102-2108, 2022 | 3 | 2022 |
Neurological misdiagnoses of lymphoma C Makranz, D Arkadir, B Nachmias, ME Gatt, R Eliahou, K Atlan, ... Neurological Sciences 42, 1933-1940, 2021 | 3 | 2021 |
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma S Gazal, E Lebel, Y Kalish, C Makranz, ME Gatt, N Goldschmidt, ... Oncology Research and Treatment 44 (1-2), 52-57, 2021 | 3 | 2021 |
Sandfly virus seroconversion associated with neurologic presentation C Makranz, H Qutteineh, H Bin, Y Lustig, JM Gomori, A Honig, AER Bayya, ... Neuroimmunology & Neuroinflammation 3 (1), e184, 2015 | 2 | 2015 |
Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study C Makranz, A Lubotzky, H Zemmour, R Shemer, B Glaser, J Cohen, ... Plos one 18 (11), e0285646, 2023 | 1 | 2023 |
Cognitive Retraining and Functional Treatment (CRAFT) for adults with cancer related cognitive impairment: a preliminary efficacy study T Maeir, C Makranz, T Peretz, E Odem, S Tsabari, M Nahum, Y Gilboa Supportive Care in Cancer 31 (3), 152, 2023 | 1 | 2023 |
Lenalidomide-Related Spinal Cord Infarction in Primary Amyloidosis C Makranz, B Nachmias, ME Gatt, R Eliahou, A Lossos Archives of Clinical and Medical Case Reports 2 (4), 124-128, 2018 | 1 | 2018 |